AstraZeneca smashes forecasts in Q2 after seeing off Pfizer
July 31, 2014 at 02:18 AM EDT
LONDON, July 31 (Reuters) - AstraZeneca smashed forecasts for second-quarter sales and earnings on Thursday, demonstrating resilience after seeing off a $118 billion takeover approach from rival drugmaker Pfizer two months ago.
